RecruitingNCT03967600

Clinical and Biological Characteristics of Hidradenitis Suppurativa

Sponsor

University of California, San Francisco

Enrollment

1,000 participants

Start Date

Jul 15, 2016

Study Type

OBSERVATIONAL

Conditions

Hidradenitis Suppurativa

Summary

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Eligibility

Min Age: 13 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with hidradenitis suppurativa. The study is currently recruiting participants at 1 location. People eligible for this study include aged 13 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

University of California, San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03967600

Related Trials

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

NCT0688819314 locations

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

NCT0692185018 locations

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

NCT076654374 locations

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT05889182285 locations

Myriad™ Augmented Soft Tissue Reconstruction Registry

NCT0524396615 locations